FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1302-1304 October 21, 1999 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ziesche, R. PubMed Citation

Idiopathic pulmonary fibrosis is a chronic condition of the lung parenchyma involving progressive injury, inflammation, and fibrosis. Data collected from October 1988 through September 1990 in the population-based registry of patients with diffuse lung disease in Bernalillo County, New Mexico, suggest that the prevalence of this disease is roughly 20 cases per 100,000 men and 13 per 100,000 women.¹ Idiopathic pulmonary fibrosis has the highest mortality of all of the diffuse lung diseases. Mortality rates from the disease almost doubled in England and Wales between 1979 and 1988,² an increase that was not due to differences in the way the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Rogliani, P., Mura, M., Assunta Porretta, M., Saltini, C. (2008). Review: New perspectives in the treatment of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2: 75-93 [Abstract]  
• Bouros, D., Antoniou, K. M. (2005). Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 26: 693-703 [Abstract] [Full Text]  
• Aghanouri, R., Ghanei, M., Aslani, J., Keivani-Amine, H., Rastegar, F., Karkhane, A. (2004). Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am. J. Physiol. Lung Cell. Mol. Physiol. 287: L1160-L1164 [Abstract] [Full Text]  
• Offit, P. A., Hackett, C. J. (2003). Addressing Parents' Concerns: Do Vaccines Cause Allergic or Autoimmune Diseases?. Pediatrics 111: 653-659 [Abstract] [Full Text]  
• Antoniou, K. M., Ferdoutsis, E., Bouros, D. (2003). Interferons and Their Application in the Diseases of the Lung. Chest 123: 209-216 [Abstract] [Full Text]  
• du Bois, R.M., Wells, A.U. (2001). Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. Eur Respir J 18: 43S-55s [Abstract] [Full Text]  
• Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., Strieter, R. M. (2000). CXC chemokines in angiogenesis. J. Leukoc. Biol. 68: 1-8 [Abstract] [Full Text]  
• King, T. E., Ziesche, R., Block, L.-H., Bois, R.M. d. (2000). Interferon Gamma-1b for the Treatment of Idiopathic Pulmonary Fibrosis. NEJM 342: 974-975 [Full Text]  
• (1999). Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis. JWatch General 1999: 3-3 [Full Text]